Cathay Biotech Inc (688065) — Cash Flow Quality Index
Cathay Biotech Inc (688065) has a Cash Flow Quality Index of -0.47x as of September 2025. Operating cash flow of CN¥-66.22 Million is below net income of CN¥142.01 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore Cathay Biotech Inc balance sheet assets for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cathay Biotech Inc Cash Flow Quality Index (2016–2024)
Historical Cash Flow Quality Index for Cathay Biotech Inc across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Cathay Biotech Inc tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Cathay Biotech Inc (2016–2024)
Year-by-year earnings quality comparison for Cathay Biotech Inc. For live market cap and the full company financial profile, see Cathay Biotech Inc (688065) market capitalisation.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.73x | CN¥820.93 Million | CN¥474.59 Million | ▲ +11.3% |
| 2023 | 1.55x | CN¥569.45 Million | CN¥366.52 Million | ▲ +18.4% |
| 2022 | 1.31x | CN¥803.67 Million | CN¥612.65 Million | ▲ +42.8% |
| 2021 | 0.92x | CN¥594.18 Million | CN¥646.68 Million | ▼ -18.4% |
| 2020 | 1.13x | CN¥514.96 Million | CN¥457.34 Million | ▲ +49.9% |
| 2019 | 0.75x | CN¥359.62 Million | CN¥478.88 Million | ▲ +3504.1% |
| 2018 | -0.02x | CN¥-10.29 Million | CN¥466.29 Million | ▼ -113.7% |
| 2017 | 0.16x | CN¥53.45 Million | CN¥332.73 Million | ▲ +118.2% |
| 2016 | -0.88x | CN¥-128.67 Million | CN¥145.47 Million | — |